ISPOR Europe 2026
Panel Patient-Centered Evidence track
Small Sample, Big Decisions: Patient Preference Data for Regulatory and Payer Uses in Rare Diseases
Wed, Nov 11, 2026 · 10:00–11:00 AM CET Hall G1, Level -2, Austria Center Vienna
About this session
ISSUE: Development and commercialisation of therapies for rare diseases is difficult for a variety of reasons, including lack of established endpoint hierarchy or inadequate understanding of the distribution of symptoms and their impacts in the population.
Speakers
-
Kielo Research
Moderator
-
UCB
Panelist
